U. S. authorities on Wednesday approved Medtronic’s $43 billion merger with Covidien after requiring the spinoff of a drug-coated catheter business.
from WSJ.com: US Business http://ift.tt/15Aiz4Y
via IFTTT
from WSJ.com: US Business http://ift.tt/15Aiz4Y
via IFTTT
No comments:
Post a Comment